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Abstract Endocytosis of the fluid phase marker, horse radish 
peroxidase, into baby hamster kidney cells is inhibited by treat- 
ment of cells with the fungal metabolite wortmannin. The ICso of 
approximately 5 nM is consistent with the well-described action 
of wortmannin upon phosphatidylinositol (PI) 3-kinase. Analysis 
of the kinetics of uptake indicates a > 50% decrease in the initial 
rate of marker internalisation, a concomitant decrease in the 
volume of the early endosome and an increased efficiency of 
recycling of that marker which is internalised. As PI 3-kinase 
binds to activated growth factor receptors our data suggest hat 
receptor activation can be coupled to receptor internalisation 
(down regulation) by localising PI 3-kinase stimulation of endocy- 
tosis. 
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1. Introduction 
Phosphatidylinositol (PI) 3-kinase is a signalling protein 
which is activated upon stimulation by a number of growth 
factor receptors (reviewed in [1]). It is a stable heterodimer 
comprising a 110 kDa catalytic sub-unit and an 85 kDa regula- 
tory sub-unit [2] which binds, via SH 2 domains, to phosphoty- 
rosine containing sequences of activated receptors. The 110 
kDa catalytic sub-unit has been shown to be related to the yeast 
S. cerevisiae Vps34 protein which is involved in sorting of 
proteins to the vacuole [3]. Due to the conservation f mecha- 
nism between yeast and mammalian cells and between various 
intracellular membrane trafficking events [4,5] a more wide- 
spread function in membrane trafficking for PI 3-kinase has 
therefore been proposed. 
The fungal metabolite wortmannin has become an important 
tool for the investigation f mammalian PI 3-kinase function. 
It was originally identified as an inhibitor of myosin light chain 
kinase [6], but recent work has shown that it will specifically 
inhibit PI 3-kinase at 100-fold lower concentrations [6,7,8,9]. 
Wortmannin covalently modifies the catalytic sub-unit of PI-3 
kinase [8]. A study of neutrophils determined that the only 
discernible protein labelled by a radioactive derivative of wort- 
mannin over the relevant concentration range was indeed the 
110 kDa sub-unit. Use of this drug has revealed a requirement 
for PI 3-kinase kinase activity in several examples of regulated 
exocytosis [8,10] and our laboratory has recently obtained evi- 
dence for involvement of a wortmannin sensitive factor in an 
in vitro assay of early endosome fusion (Jones and Clague, 
manuscript submitted). In this paper we show that wortmannin 
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exerts a profound inhibition upon the fluid phase endocytic 
uptake of horseradish peroxidase (HRP) into baby hamster 
kidney (BHK) cells. These data support he idea that interac- 
tion with PI 3-kinase is an important factor in the down regu- 
lation of activated receptor tyrosine kinases [11]. 
2. Materials and methods 
Cell culture reagents were from Gibco, HRP was from Biozyme, 
wortmannin was from Sigma. 
Confluent monolayers ofBHK cells were split 1:4 into 35 mm diam- 
eter dishes the day before an experiment. 30 rain before commencing 
the experiment the indicated concentration f wortmannin was added. 
Immediately prior to the experiment, cells were washed with Dulbecco's 
phosphate buffered saline (DPBS) at room temperature. At time zero, 
dishes were transferred toa metal plate held at 37°C, whilst simultane- 
ously exchanging the DPBS for prewarmed (37°C) Dulbeccos Modified 
Eagles Medium (DMEM) supplemented with 20 mM HEPES, 5 mM 
D-glucose (pH 6.85) and the indicated concentrations of HRP. 
After the indicated incubation time, the cells were washed exten- 
sively, on a rocking metal plate held at 4°C, by 10 × 5 rain incubations 
with DPBS supplemented with 1% bovine serum albumin followed by 
2 rinses with cold DPBS. Liquid in the dishes was aspirated offand then 
0.25 ml of 1% Triton X-100 was added to each dish and incubated on 
a rocker at room temperature for 5 min. This liquid was then trans- 
ferred to a microfuge tube and spun at 5,000 × g for one minute. The 
HRP activity of an aliquot of each supernatant was then determined 
by a colourimetric assay at 455 nm using o-dianisodine and H202 as 
substrates. 
3. Results and discussion 
Wortmannin s a potent inhibitor of fluid phase endocytosis 
in BHK cells. Fig. 1 shows the dose-response towards wort- 
mannin for a 20 min HRP internalisation. HRP uptake by the 
cell, is less than 25% the control value at wortmannin concen- 
trations >20 nM. We found some variation between experi- 
ments in terms of the absolute level of maximal inhibition at 
this time point, within the range 50-80% inhibition. Experi- 
ments were performed at an external pH of 6.85, which ampli- 
fied the inhibitory effect about 1.5-fold (data not shown), with- 
out significantly affecting HRP internalisation, i  accordance 
with the findings of Davoust et al. [12]. The ICs0 of approxi- 
mately 5 nM is entirely consistent with inactivation of PI 3- 
kinase. Whilst this demonstrates a profound effect on the endo- 
cytic pathway, the reduction at this time point could be due to 
either decreased uptake or increased recycling. We therefore 
investigated the effects of 25 nM wortmannin on HRP uptake 
at other time points (Figs. 2 and 3). The measured absorbance 
is proportional to HRP concentration ver the recorded range 
of Fig. 2; however, in order to obtain a measurable signal after 
only one minute of internalisation we conducted a separate 
experiment using a higher concentration f HRP in the inter- 
nalisation medium (6 mg/ml) (Fig. 3). 
Measurement of fluid phase uptake by the cell reveals that 
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Fig. 1. Dose response for wortmannin hibition of fluid phase uptake 
of HRP. 2 mg/ml HRP was incubated with BHK cells for 20 min at 
37°C. Cells were treated with the indicated concentrations ofwortman- 
nin for 30 min prior to commencement of he internalisation, y-Axis 
units are arbitrary. 
it is biphasic (Fig. 2). This is because in the early stages of the 
incubation the uptake rate corresponds purely to the rate of 
internalisation, but as HRP enters recycling compartments the 
uptake rate at longer time points will correspond to the inter- 
nalisation rate minus the recycling rate. At steady state this will 
correspond to the rate of transfer to non-recycling compart- 
ments. From Figs. 2 and 3 it is evident hat the initial rate of 
HRP internalisation after wortmannin treatment is about half 
of the control value. The time point at which the initial slope 
(Fig. 2) intersects with the final slope gives us an indicator of 
the time to fill the early endosomal compartment and is close 
to 10 min in each case. This implies that the volume of the early 
endosome must decrease in response to wortmannin. As the 
proportionate volume decrease is essentially the same as the 
decrease in initial internalisation rate, one can naturally con- 
clude that internalisation rate determines early endosome vol- 
ume. Reduced volume of the early endosome is consistent with 
both a maturationist [13] and stable compartmentalist [14] view 
of the early endosome. An alternative interpretation of this 
aspect of the data can be fitted to the maturationist framework, 
this would require that wortmannin creases the rate at which 
maturing endosomes become refractory to incoming material. 
Recycling (indirectly measured as initial slope-final slope; 
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Fig. 2. Time course of HRP internalisation (2 mg/ml HRP) into BHK 
cells at 37°C. Filled triangles correspond todata points for control cells, 
filled circles are data points for cells treated with 25 nM wortmannin 
for 30 min prior to commencement of internalisation, y-Axis units are 
arbitrary. 
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Fig. 3. HRP internalised after 1 rain at 37°C by control cells and cells 
treated with 25 nM wortmannin for 30 rain prior to commencement of 
internalisation, y-Axis units are arbitrary. 
Fig. 2) is 1.9 times greater in control cells, whereas the rate of 
entry into non-recycling compartments (final slopes, Fig. 2) is 
3.3 times greater, therefore within endosomal compartments 
wortmannin treatment favours recycling of fluid phase marker, 
but this may be an indirect effect. This associated phenomenon 
does not affect the principal finding of this paper, namely that 
initial fluid phase internalisation steps are PI 3-kinase depend- 
ent. 
We believe that effects of wortmannin reflect an inhibition 
of a clathrin coated vesicle-mediated uptake pathway, because 
this has been shown to account for most of the constitutive fluid 
phase uptake into BHK cells [12,15]. However, it will be impor- 
tant to confirm our interpretation using an electron micro- 
scopic approach. It may be that PI-3 kinase plays a general role 
in budding of clathrin coated vesicles within the cell including 
those emanating from the trans-Golgi network. The S. cerevis- 
iae protein Vps34p, which is homologous to the PI 3-kinase 110 
kDa catalytic sub-unit, is involved in sorting of proteins to the 
vacuole, a process which has also been shown to be clathrin- 
dependent [16]. It will be interesting tosee if effects of wortman- 
nin are observed on trafficking of lysosomal proteins in mam- 
malian cells. 
Attention on the role of PI-3 kinase in endocytic events has 
thus far focussed on internalisation f activated receptors with 
which it interacts; in particular the platelet derived growth 
factor (PDGF) receptor. Mutant PDGF receptors lacking a PI 
3-kinase binding motif were expressed in human Hep G2 cells. 
On stimulation, wild type receptors internalised and concen- 
trated in a juxtanuclear region whereas the mutant receptors 
remained at the cell periphery [11]. One uncertainty with these 
observations i  that the mutated section of the protein also 
binds the SH2-SH3-containing protein Nck and therefore the 
requirement for PI 3-kinase binding has not been established 
unequivocably. We have now shown by the criterion of wort- 
mannin sensitivity that PI 3-kinase activity enhances constitu- 
tive endocytosis. Translocation of the enzyme to the plasma 
membrane following receptor activation might therefore be 
expected to enhance fluid phase endocytosis. Indeed, treatment 
of human fibroblasts with EGF has been shown to enhance 
fluid phase uptake 2.5-fold [17]. This suggests a simple model 
to couple activation of receptor to its internalisation. PI
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Fig. 4. Diagram indicating proposed model for internalisation f acti- 
vated growth factor receptor by local generation of 3-PIs and their 
possible stimulation of dynamin GTPase activity (see text for de- 
tails).The ssential element of the model is the stimulation by 3-PIs of 
an activity required for endocytosis, which is localised to their point of 
production by association with p85. This would also apply for target 
proteins other than dynamin. 
3-kinase binds to activated receptor, which would then simply 
localise endocytosis stimulating activity to the vicinity of the 
receptor. Further experiments will be required to completely 
rule out alternative models in which PI 3-kinase stimulates 
receptor internalisation by enhanced sorting into clathrin 
coated pits forming independently of receptor activation. 
Wortmannin inhibits lipid kinase activity but does not affect 
growth factor-induced translocation of the p85/p110 complex 
[18]. This raises the question as to the means by which genera- 
tion of 3-phosphorylated phosphatidylinositols can lead to en- 
hanced endocytosis. It has recently been shown that dynarnin, 
a protein required for clathrin mediated endocytosis [19,20], 
can bind to the SH3 domain of p85 [21]. It follows that p85 
might act as a three-way adaptor protein, and that this linkage 
of receptor, PI 3-kinase and dynamin is integral to the receptor 
internalisation mechanism. As wortmannin seems more likely 
to affect lipid kinase activity rather than this association, we 
propose a coupling between phospholipid generation and dy- 
namin activity as a speculative interpretation of our findings 
(Fig. 4). Acidic phospholipids have been shown to stimulate the 
GTPase activity of dynamin [22], so it could be that 3- 
phosphorylated phosphatidylinositols, generated by PI 3-ki- 
nase, stimulate the GTPase activity of adjacent dynamin, which 
has been shown to be required for endocytosis [19]. 
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